Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids.
An oral dose of all-trans-retinoic acid or 13-cis-retinoic acid in the pregnant [Lak:LVG(SYR)] hamster caused a dose-dependent increase in malformations in the offspring, but an equivalent dose of all-trans-N-ethyl retinamide or 13-cis-N-ethyl retinamide failed to result in embryotoxicity. The present results show that structural modification of the retinoid skeleton can produce compounds that retain cancer chemopreventive activity but that lack the teratogenic activity common to many synthetic and naturally occurring forms of vitamin A. The results indicate that in the case of the retinoids the two kinds of activity--interference with the process of carcinogenesis and interference with embryonic development--may be divorced.
D000014:Abnormalities, Drug-Induced / Q000473:pathology*; D000818:Animals; D006224:Cricetinae; D010064:Embryo Implantation; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D005327:Fetal Resorption; D005333:Fetus / Q000187:drug effects; D011247:Pregnancy; D013329:Structure-Activity Relationship; D013723:Teratogens; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000633:toxicity*
D013723:Teratogens; D014212:Tretinoin